[PRESSWIRE] Austria - 04 May, 2021 -- CEBINA GmbH, an Austrian biotech company, today announces that azelastine, previously identified as a potential anti-COVID-19 drug, is equally potent against newly emerging dominant variants of SARS-CoV-2 compared to the original virus. Azelastine is available as an anti-allergy nasal spray and is currently being tested in a Phase 2 efficacy trial for the treatment of early-stage COVID-19 disease.

[PRESSWIRE] New York, NY - Art State Productions, Inc. announces the launch of a crowdfunding campaign for Journey of Life™, an educational animated series approaching education through entertainment for the healthy emotional development of the child.

[PRESSWIRE] Vienna, Austria - 17 February, 2021 -- In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts around the world are focusing on identifying new anti-COVID therapeutics that includes re-evaluation of existing product portfolios with a view to re-purpose drugs that have antiviral properties.

[PRESSWIRE] SANTA ANA, January 26, 2021 -- Airionex, the leading global provider of bi-polar ionization air and surface purification technology, announced today that it has hired Françoise Parker as Senior Vice President of Sales and Marketing. Françoise will report to CEO Jukka Matikka, and will be responsible for sales team leadership, accelerating Airionex revenue throughout North America, the development and management of key channels, and overseeing the company’s marketing strategy.

[PRESSWIRE] Madrid, Spain - 25 January, 2021 -- An innovative new technology from Necenti Labs offers 96% accuracy for COVID-19 detection before infection with deep data to give companies and individuals the power of knowledge to battle lockdown.

[PRESSWIRE] Germany - 21 December, 2020 -- N-PATH is the most innovative European training course in interventional nephrology funded by European Commission in the framework of the Erasmus+ program coordinated by the University of Bari, in collaboration with the European Renal Association (ERA-EDTA), the Vascular Access Society, important international academic centers and two companies specialized in medical training.

[PRESSWIRE] Austria - 19.11.20 -- Eveliqure Biotechnologies GmbH, a clinical-stage biotechnology company, today announces the publication of preclinical data with ShigETEC, its vaccine candidate against Shigellae and Enterotoxic E. coli in the peer-reviewed journal Vaccines (https://doi.org/10.3390/vaccines8040689).

[PRESSWIRE] UK - 18.11.20 -- Hundreds of religious leaders from around the world gather to pray for the end of COVID-19 ahead of a group plasma donation by 4,000 Shincheonji members...

New policy framework for digital governance calls for fundamental re-set of data regulation across telecoms and technology industries.

[PRESSWIRE] London, UK - 21 October, 2020 -- The new series of e-seminars is designed to give participants a compre­hensive update on current issues and to encourage vibrant discussions. The underlying idea is to bridge the gap between research and practice by communicating and analyzing the findings from recent studies and thus to implement them in clinical practice. Another set of e-seminars will focus on the current state of the art in diagnosing and treating the various nephrological indications, which will be particularly interesting for young doctors and/or PA students.